Clinical trial

A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously…

NCT00465465 · University of Oxford, Other · Completed

Key facts

NCT number NCT00465465
Title A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG
Official title A Dose Selection Study Evaluating the Safety and Immunogenicity of 2 Different Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Have Previously Been Vaccinated With BCG
Lead sponsor University of Oxford, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Tuberculosis
Intervention type Biological
Interventions MVA 85A
Enrollment 24
Start date Oct 1, 2005
Primary completion Sep 1, 2007
Completion Sep 1, 2007
First posted Apr 25, 2007
Last update posted Apr 4, 2008
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies